We are live on ! Find out more
TECH icon

Bio-Techne

556 hedge funds and large institutions have $16.2B invested in Bio-Techne in 2022 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 199 increasing their positions, 209 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

269% more call options, than puts

Call options by funds: $30.2M | Put options by funds: $8.18M

8.03% more ownership

Funds ownership: 376.15%384.18% (+8%)

5% less repeat investments, than reductions

Existing positions increased: 199 | Existing positions reduced: 209

3% less funds holding

Funds holding: 575556 (-19)

14% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 76

15% less capital invested

Capital invested by funds: $19.1B → $16.2B (-$2.9B)

20% less funds holding in top 10

Funds holding in top 10: 1512 (-3)

Holders
556
Holders Change
-19
Holders Change %
-3.3%
% of All Funds
8.77%
Holding in Top 10
12
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-20%
% of All Funds
0.19%
New
65
Increased
199
Reduced
209
Closed
76
Calls
$30.2M
Puts
$8.18M
Net Calls
+$22M
Net Calls Change
+$14.6M
Name Holding Trade Value Shares
Change
Change in
Stake
FAF
176
Fjarde Ap-fonden
Sweden
$4.72M +$536K +5,200 +14%
MCM
177
McKinley Capital Management
Alaska
$4.43M
CSS
178
Cubist Systematic Strategies
Connecticut
$4.33M -$191K -1,856 -4%
SOMRS
179
State of Michigan Retirement System
Michigan
$4.29M +$4.54K +44 +0.1%
LPL Financial
180
LPL Financial
California
$4.22M +$84.6K +820 +2%
OPERF
181
Oregon Public Employees Retirement Fund
Oregon
$4.17M +$16.5K +160 +0.4%
SFI
182
Susquehanna Fundamental Investments
Pennsylvania
$4.02M +$3.83M +37,092 New
CCM
183
Cinctive Capital Management
New York
$3.99M +$3.8M +36,836 New
OAC
184
OMERS Administration Corp
Ontario, Canada
$3.96M +$282K +2,732 +8%
Skandinaviska Enskilda Banken (SEB)
185
Skandinaviska Enskilda Banken (SEB)
Sweden
$3.88M -$673K -6,520 -15%
Cerity Partners
186
Cerity Partners
New York
$3.88M +$92K +892 +3%
Rockefeller Capital Management
187
Rockefeller Capital Management
New York
$3.88M -$864K -8,376 -19%
SDIC
188
South Dakota Investment Council
South Dakota
$3.82M -$1.03M -10,000 -22%
Susquehanna International Group
189
Susquehanna International Group
Pennsylvania
$3.75M -$4.26M -41,272 -54%
Nomura Asset Management
190
Nomura Asset Management
Japan
$3.71M +$236K +2,288 +7%
Los Angeles Capital Management
191
Los Angeles Capital Management
California
$3.69M +$82.5K +800 +2%
Zurich Cantonal Bank
192
Zurich Cantonal Bank
Switzerland
$3.68M
EIP
193
Epoch Investment Partners
New York
$3.67M +$3.5M +33,892 New
ProShare Advisors
194
ProShare Advisors
Maryland
$3.6M -$95.3K -924 -3%
JMPWA
195
JP Morgan Private Wealth Advisors
California
$3.58M -$66.9K -648 -2%
Teacher Retirement System of Texas
196
Teacher Retirement System of Texas
Texas
$3.51M +$209K +2,024 +7%
CWM
197
CIBC World Markets
New York
$3.5M +$277K +2,680 +9%
Truist Financial
198
Truist Financial
North Carolina
$3.45M -$30.1K -292 -0.9%
FAF
199
Första AP-fonden
Sweden
$3.38M -$289K -2,800 -8%
Comerica Bank
200
Comerica Bank
Texas
$3.31M -$693K -6,720 -18%

TECH Hedge Fund Activity: Q1 2022 in Review

556 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2022, worth a combined $16.2B — down 15% from $19.1B a quarter earlier.

Sellers outnumbered buyers: 76 funds closed out of TECH and 65 opened new positions — a net loss of 11 holders — while 209 trimmed existing stakes and 199 added.

The largest buyer was Select Equity Group, opening a new position worth an estimated $288M. The largest seller was Marshall Wace, cutting an estimated $125M.

  • 556 institutional investors held Bio-Techne (TECH) as of Q1 2022, down from 575 in Q4 2021.
  • Funds reported $16.2B of Bio-Techne stock for Q1 2022, down 15% quarter-over-quarter.
  • 65 funds opened new Bio-Techne positions in Q1 2022 and 76 closed out, a net change of -11 holders.
  • The largest Bio-Techne buyer in Q1 2022 was Select Equity Group, an estimated $288M added.
  • The largest Bio-Techne seller in Q1 2022 was Marshall Wace, an estimated $125M sold.

Based on aggregated 13F filings for Q1 2022.